Literature DB >> 12556363

Tetanus toxin abolishes exocytosis of ROMK1 induced by inhibition of protein tyrosine kinase.

Hyacinth Sterling1, Dao-Hong Lin, Yuan Wei, Wen-Hui Wang.   

Abstract

We used confocal microscopy, patch-clamp, and biotin-labeling techniques to examine the role of soluble N-ethylmaleimide-sensitive factor attachment protein receptor (SNARE) proteins in mediating the effect of inhibition of PTK on ROMK1 trafficking in HEK-293 cells transfected with c-Src and green fluorescent protein (GFP)-ROMK1. Inhibition of c-Src with herbimycin A significantly decreased the tyrosine phosphorylation level of ROMK1. Patch-clamp studies demonstrated that addition of herbimycin A increased the activity of ROMK1 in cell-attached patches. Confocal microscopic imaging showed that herbimycin A decreased the intracellular intensity of GFP-ROMK1. The biotin-labeling technique demonstrated that the inhibition of c-Src increased surface ROMK1 by 110%. In contrast, inhibition of c-Src did not increase the K channel number in HEK cells transfected with R1Y337A, a ROMK1 mutant in which tyrosine residue 337 was mutated to alanine. This suggests that tyrosine residue 337 is essential for the herbimycin A-induced increase in surface ROMK1 channels. To determine whether SNARE proteins are involved in mediating exocytosis of ROMK1 induced by the inhibition of c-Src, we examined the effect of herbimycin A on ROMK1 trafficking in cells treated with tetanus toxin. The incubation of cells in a medium containing tetanus toxin abolished the herbimycin A-induced increase in the number of surface ROMK1. In contrast, inhibition of c-Src still increased the numbers of surface ROMK1 in cells treated with boiled tetanus toxin. We conclude that tyrosine dephosphorylation enhances the exocytosis of ROMK1 and that SNARE proteins are required for exocytosis induced by inhibition of PTK.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12556363     DOI: 10.1152/ajprenal.00309.2002

Source DB:  PubMed          Journal:  Am J Physiol Renal Physiol        ISSN: 1522-1466


  8 in total

1.  Mitogen-activated protein kinases inhibit the ROMK (Kir 1.1)-like small conductance K channels in the cortical collecting duct.

Authors:  Elisa Babilonia; Dimin Li; Zhijian Wang; Peng Sun; Dao-Hong Lin; Yan Jin; Wen-Hui Wang
Journal:  J Am Soc Nephrol       Date:  2006-09-13       Impact factor: 10.121

Review 2.  Regulation of ROMK (Kir1.1) channels: new mechanisms and aspects.

Authors:  Wen-Hui Wang
Journal:  Am J Physiol Renal Physiol       Date:  2006-01

3.  Inhibition of non-receptor tyrosine kinase Src induces phosphoserine 256-independent aquaporin-2 membrane accumulation.

Authors:  Pui W Cheung; Abby Terlouw; Sam Antoon Janssen; Dennis Brown; Richard Bouley
Journal:  J Physiol       Date:  2018-12-21       Impact factor: 5.182

Review 4.  Thick Ascending Limb Sodium Transport in the Pathogenesis of Hypertension.

Authors:  Agustin Gonzalez-Vicente; Fara Saez; Casandra M Monzon; Jessica Asirwatham; Jeffrey L Garvin
Journal:  Physiol Rev       Date:  2019-01-01       Impact factor: 37.312

5.  Protein tyrosine kinase is expressed and regulates ROMK1 location in the cortical collecting duct.

Authors:  Dao-Hong Lin; Hyacinth Sterling; Baofeng Yang; Steven C Hebert; Gerhard Giebisch; Wen-Hui Wang
Journal:  Am J Physiol Renal Physiol       Date:  2004-05

6.  Inhibition of ROMK channels by low extracellular K+ and oxidative stress.

Authors:  Gustavo Frindt; Hui Li; Henry Sackin; Lawrence G Palmer
Journal:  Am J Physiol Renal Physiol       Date:  2013-05-15

Review 7.  Regulation of potassium (K) handling in the renal collecting duct.

Authors:  Wen-Hui Wang; Gerhard Giebisch
Journal:  Pflugers Arch       Date:  2008-10-07       Impact factor: 3.657

8.  Vesicle-associated membrane protein-2 (VAMP2) mediates cAMP-stimulated renin release in mouse juxtaglomerular cells.

Authors:  Mariela Mendez; Kenneth W Gross; Sean T Glenn; Jeffrey L Garvin; Oscar A Carretero
Journal:  J Biol Chem       Date:  2011-06-27       Impact factor: 5.157

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.